97928-18-2Relevant academic research and scientific papers
PROCESS OF PREPARING EBASTINE
-
Page/Page column 9, (2012/06/30)
The present invention relates to a novel process for the preparation of pure Ebastine and use of the same in formulation without micronising. The invention further relates to the process of preparation of 1 -[4-(1, 1 -dimethyl ethyl) phenyl] -4-(4-hydroxy piperidin-1-yl) butan-1-one (compound II), an intermediate or preparation of Ebastine and use of the same in the preparation of pure Ebastine with the maximum particle size more than 1000 μm and D90 from 250 μm -1000 μm.
Synthesis of [2H5]-ebastine fumarate and [ 2H5]-hydroxyebastine
Yu, Zhoujie,Wang, Wei,Chen, Liqin
experimental part, p. 352 - 356 (2012/06/01)
This study describes the synthesis of deuterium-labelled ebastine fumarate and its deuterium-labelled metabolite hydroxyebastine. The synthesis of the two desired compounds both used [2H5]-bromodiphenylmethane as deuterium-labelled reagent, which was synthesized beforehand in three steps. [2H5]-ebastine was synthesized in further three steps with a 27% overall yield and [2H5]-hydroxyebastine was synthesized in further seven steps with a 13% overall yield.
PROCESS OF PREPARING EBASTINE
-
Page/Page column 8-9, (2010/01/30)
The present invention relates to a novel process for preparing ebastine from 1-[4-(1,1-dimethylethyl) phenyl]-4-(4-hydroxy piperidin-1-yl) butan-1-one and diphenyl methanol, which is easily reproducible on an industrial scale. A process for preparation of 1-[4-(1,1-dimethylethyl) phenyl]-4-(4-hydroxy piperidin-1-yl) butan-1-one.
Piperidine derivatives
-
, (2008/06/13)
Compounds of the general formula I: STR1 wherein R1 represents a thienyl group, or a phenyl group optionally substituted by a halogen (preferably fluorine or chlorine) atom, a lower alkoxy or lower alkyl group, R2 represents a hydrogen or halogen (preferably fluorine) atom, a lower alkoxy or lower alkyl group, R3 represents a hydrogen or halogen (preferably fluorine) atom, a lower alkylthio, lower alkoxy or lower alkyl group, or a cycloalkyl group containing 5 or 6 carbon atoms, or a group of the general formula: STR2 wherein R4 and R5 singly each represents a hydrogen atom or lower alkyl group, R6 represents a cycloalkyl, hydroxymethyl, carboxy or lower alkoxycarbonyl group, and W represents a carbonyl STR3 or a hydroxymethylene [viz. --CH(OH)--] group, and pharmacologically acceptable salts thereof possess potent selective Histamine H1 -receptor blocking and calcium antagonist properties and are of interest in the treatment of a variety of respiratory, allergenic and cardiovascular disease states. The new compounds can be prepared by various methods based on the condensation of α-substituted benzyl halides with N-(benzoylpropyl or phenyl-hydroxypropyl)-4-hydroxy piperidines or condensation of di-substituted-methoxy-piperidines with a benzoylpropyl halide or a phenyl-hydroxypropyl-halide followed, where necessary, by removal of protecting groups.
